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Abstract
Background—Patients with alcoholic liver disease have been reported to have a significantly 
lower percentage of body fat (%BF) than controls. The mechanism for the reduction in %BF in 
heavy alcohol users has not been elucidated. In adipose tissue, Pref-1 is specifically expressed in 
pre-adipocytes but not in adipocytes. Pref-1 inhibits adipogenesis and elevated levels are 
associated with reduced adipose tissue mass. We investigated the association between serum 
Pref-1 and %BF, alcohol consumption, and serum free fatty acids (FFA) in a well-characterized 
cohort of heavy alcohol users compared to controls.
Methods—One hundred forty-eight subjects were prospectively recruited. The Time Line 
Follow-Back (TLFB) questionnaire was used to quantify the amount of alcohol consumed over the 
30-day period before their enrollment. Anthropometric measurements were performed to calculate 
%BF. Serum Pref-1 and FFA were measured.
Results—Fifty-one subjects (mean age 32 ± 9 years, 88% men) were non-excessive drinkers 
whereas 97 were excessive drinkers (mean age 41 ± 18 years, 69% men). Compared to non-
excessive drinkers, individuals with excessive drinking had significantly higher levels of Pref-1 (p 
< 0.01), FFA (p < 0.001), and lower %BF (p = 0.03). Serum levels of Pref-1 were associated with 
the amount of alcohol consumed during the previous 30 days. Serum Pref-1 was negatively 
correlated with %BF, but positively associated with serum FFA.
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Conclusions—Our data suggest that elevated Pref-1 levels in excessive drinkers might inhibit 
the expansion of adipose tissue, decreasing %BF in alcoholics. Further work is needed to validate 
these findings and to better understand the role of Pref-1 and its clinical significance in subjects 
with heavy alcohol use.
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Introduction
Adipose tissue is a metabolically active tissue that plays important roles in the risk and 
pathogenesis of chronic liver diseases, in particular those related to insulin resistance and the 
metabolic syndrome (Lumeng, 2010; Vuppalanchi & Chalasani, 2009). There are interesting 
and unexplained interactions between alcohol intake and fat metabolism. Studies of body 
composition of alcoholics vs. weight-matched controls (Addolorato et al., 2000) showed that 
heavy drinkers had significantly lower body fat mass, suggesting that they were less capable 
of storing ethanol-derived or other calories as fat compared with controls. These changes 
were reversible with 3 months of abstinence, coincident with restoration of a normal body 
fat mass (Addolorato, Capristo, Greco, Caputo, et al., 1998; Addolorato, Capristo, Greco, 
Stefanini, & Gasbarrini, 1997, 1998). On the other hand, moderate alcohol use does not 
change metabolic rate, post-prandial free fatty acids, or insulin levels (Contaldo et al., 1989). 
Thus, the interaction between drinking and adipose tissue biology depends on the level of 
alcohol consumption. Using the large population-based data of the third National Health and 
Nutrition Examination Survey (NHANES), we have found that there is a decrease in 
percentage of body fat (%BF) as alcohol use increases (Liangpunsakul, Crabb, & Qi, 2010).
The findings of reduced fat mass in heavy drinkers might have clinical consequences. 
Recent studies showed that the interaction between liver and adipose tissue plays an 
important role in whole body lipid homeostasis. In physiological states, white adipose tissue 
is the major organ to store excess energy (i.e., under positive energy balance conditions) in 
the form of triglycerides (TG), and it provides the major source of energy for other tissues 
by releasing fatty acids under negative energy balance conditions. Decreasing body fat and 
its storage in adipose tissue may cause excess fatty acid influx into the liver, leading to 
hepatic steatosis (Cusi, 2010; Lafontan & Girard, 2008; Wree, Kahraman, Gerken, & 
Canbay, 2011). In fact, a few clinical studies have demonstrated that lower fat mass is 
associated with higher liver fat in alcoholics (Addolorato et al., 1997; Addolorato, Capristo, 
Greco, Stefanini, et al., 1998).
Reduced fat mass in heavy drinkers suggests either loss of stored lipid in the form of TG or 
reduced differentiation of pre-adipocytes into mature adipocytes. Reduction of adipocyte 
size due to loss of stored lipid might be related to alcohol-induced hyperlipolysis (Zhong et 
al., 2012).
Adipocytes arise from pre-adipocytes that undergo commitment and differentiation to 
mature adipocytes (Sul, 2009). Pre-adipocyte factor-1 (Pref-1) is a 385-amino acid protein 
and a member of the epidermal growth factor-like family of proteins. It is highly expressed 
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in pre-adipocytes but decreases during the process of differentiation and is absent in mature 
adipocytes. In fact, high levels of Pref-1 inhibit adipogenesis (Sul, 2009). Previously, our 
group showed that alcohol inhibits the differentiation of pre-adipocytes into adipocytes 
(Crabb, Zeng, Liangpunsakul, Jones, & Considine, 2011). This process might involve the 
activation of Pref-1, reflected by increased serum concentrations. The role of Pref-1 and 
body fat in human subjects with heavy alcohol use has not been studied. We hypothesized 
that excessive drinkers would have higher levels of Pref-1 than non-excessive drinkers and 
that higher Pref-1 would be associated with lower %BF. To test this hypothesis, we 
conducted a clinical study to investigate the association between serum Pref-1 and %BF, 
amount of alcohol consumption, and free fatty acid in a well-characterized cohort of 
excessive alcohol use compared to controls.
Materials and methods
Subjects
Ninety-seven subjects with a history of alcohol use disorder who were admitted for alcohol 
rehabilitation at Fairbanks Drug and Alcohol Treatment Center in Indianapolis, Indiana were 
recruited. All subjects reported the last alcohol drinking to be from 0–4 days before the 
enrollment. They all met the criteria for ‘excessive drinking’ according to the NIH/NIAAA, 
which are defined as men who drink more than 4 standard drinks in a day (or more than 14 
per week) and women who drink more than 3 standard drinks in a day (or more than 7 per 
week). Fifty-one non-excessive drinkers were recruited from Richard L. Roudebush 
Veterans Administration Medical Center in Indianapolis, Indiana. The inclusion criteria 
required subjects to be at least 21 years of age or older and to be able to provide informed 
consent. Subjects were excluded if they had active and serious medical diseases at the time 
of screening (such as congestive heart failure, chronic obstructive pulmonary disease, 
cancer, uncontrolled diabetes, and chronic renal failure), had a history of any systemic 
infection within 4 weeks prior to the study, and had a history of recent major surgeries 
within the past 3 months. The study design and protocol were approved by the Institutional 
Review Board at the Indiana University Purdue University Indianapolis (IUPUI), Richard L. 
Roudebush VAMC Research and Development Program, and at Fairbanks Alcohol 
Rehabilitation Center. Written informed consent was obtained from each participant.
Data collection
Participants completed a self-administered questionnaire. Demographic data, smoking 
history, past medical history, and the AUDIT (Alcohol use disorders identification test) 
alcohol consumption questions (AUDIT-C) were collected. In this study, the Time Line 
Follow-Back questionnaire was used to determine the amount of alcohol consumption over 
the 30-day period before the study date. A timeline follow back (TLFB) questionnaire was 
administered in person by trained study coordinators who reviewed the instructions with the 
subjects prior to administering the questionnaire, and it was completed by each subject 
during the interview. The TLFB offers a daily retrospective report of alcohol consumption 
over the previous 30 days, from which quantity, drinks per drinking occasion, and pattern of 
drinking can be obtained (Sobell et al., 1988, 2003; Vakili, Sobell, Sobell, Simco, & 
Agrawal, 2008). Memory aids (weekends and special occasions) were used to enhance recall 
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of alcohol consumption amounts. TLFB consisted of subjects' retrospective recall of the 
number of “standard” drinks (i.e., defined as the alcohol equivalent of 12 oz. of domestic 
(U.S.) beer, 5 oz. of 12%-alcohol wine, or 1.5 oz. of 80-proof distilled spirits) consumed on 
each of the previous 30 days. Participants completed a log based on a monthly calendar to 
indicate daily alcohol drinking to provide the total number of alcoholic drinks consumed in 
the previous 30 days prior to enrollment. This quantity was then divided by the total number 
of drinking days, also within the previous 30 days, to calculate drinks per drinking day. 
TLFB is established as an effective measure of drinking patterns (Collins, Kashdan, 
Koutsky, Morsheimer, & Vetter, 2008; Sobell et al., 1988). It also demonstrates a test–retest 
reliability correlation ranging from 0.86 to 0.90 for normal drinkers within the previous 30 
drinking days (Sobell et al., 1988).
Anthropometric measures
Anthropometric measures were obtained with subjects wearing hospital gowns. Height and 
weight were measured and BMI was calculated as weight (kg)/height2 (m2). Waist 
circumference was measured by trained study coordinators using a tape measure at the 
midpoint between the lower margin of the last palpable rib and the top of the iliac crest. The 
percentage of whole body fat was calculated using the waist to height ratio and age stratified 
by gender as previously described (Kagawa, Byrne, & Hills, 2008).
Laboratory measures and biochemical analyses
Laboratory evaluation included complete blood counts and comprehensive metabolic panels. 
Fasting serum from all participants was used to measure serum Pref-1 and serum free fatty 
acid. Serum Pref-1 concentrations were measured by a sandwich ELISA assay (R&D 
Systems, Inc., Minneapolis, MN; Catalog number DPRF10, sensitivity 0.034 ng/mL and 
assay range at 0.156–10 ng/mL). Serum free fatty acid concentrations were determined by 
an in vitro enzymatic calorimetric method (Wako HR series NEFA-HR[2], Richmond, VA).
Statistical analysis
The basic characteristics of the study participants are presented as mean ± S.D. for 
continuous variables and as numbers with percentages for categorical variables. Chi-square 
tests and t tests were used to compare values of categorical variables and continuous 
variables, respectively. The level and patterns of alcohol consumption during the previous 
30 days were modeled categorically into non-excessive and excessive drinking based on the 
NIAAA definition, as described above. The serum Pref-1, serum free fatty acid (FFA), and 
percentage of body fat (%BF) between these 2 groups were compared. Alcohol intake was 
also modeled as a continuous variable by calculating the total number of drinks during the 
previous 30 days from TLFB. We used linear regression models to examine the association 
between the total amount of alcohol consumed in the past month with serum Pref-1 
concentrations, FFA, and %BF. To determine the relationship of these variables and 
different levels of alcohol consumption, separate linear regression analyses were performed 
to explore the relationship between Pref-1, FFA, %BF, and the amount of alcohol 
consumption during the previous 30 days stratified by quartiles (Q1: < 26 drinks, Q2: 26–
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116 drinks, Q3: 117–273 drinks, and Q4: ≥ 273 drinks). A 2-tailed p value < 0.05 was 
considered statistically significant.
Results
One hundred forty-eight subjects were enrolled. Subjects classified as excessive drinkers (n 
= 91) were older compared to non-excessive drinkers (n = 57; mean age 41 vs. 32 years, p < 
0.01). There were no significant differences in height, weight, and body mass index as well 
as waist circumference between both groups. Excessive drinkers, as expected, had 
significantly higher AUDIT-C scores (26.7 vs. 4.2, p < 0.001). The average total drinks over 
the previous month were 241 for excessive drinkers, and 15 for non-excessive drinkers (p < 
0.001). Excessive drinkers had higher levels of MCV, AST, ALT, GGT, and %CDT. The 
detailed demographic and clinical characteristics of subjects in these 2 groups are shown in 
Table 1.
Serum levels of Pref-1 were significantly elevated in excessive drinkers and correlated 
with the amount of alcohol consumption during the previous 30 days
We found that serum concentrations of Pref-1 were significantly higher in excessive 
drinkers compared to non-excessive drinkers (0.32 ± 0.13 vs. 0.13 ± 0.06 ng/mL, p < 0.01; 
Table 1 and Fig. 1A). Additionally, serum levels of Pref-1 were significantly correlated with 
the amount of alcohol consumption as quantified by the TLFB (r2 = 0.21, p < 0.001; Fig. 
1B). In a sub-analysis, we explored the relationship between serum Pref-1 and different 
levels of alcohol consumption by quartiles. We found no association between the levels of 
serum Pref-1 and the levels of alcohol consumption in the first quartile range (Fig. 1C). We 
observed a significant association when the levels of alcohol consumption were in the 2nd–
4th quartiles range (Fig. 1D–F). Our data suggested that increasing serum Pref-1 levels were 
observed only when alcohol drinking became excessive.
The levels of alcohol consumption were negatively associated with percentage of body fat 
(%BF)
Excessive alcohol drinkers had significantly lower %BF than non-excessive drinkers (29.7% 
and 31.7%, p = 0.03). We next performed the linear regression analysis to determine the 
relationship between level of alcohol drinking and %BF. When considering the data from all 
participants, we observed a trend in the paradoxical relationship between the percentage of 
body fat and the amount of alcohol consumed (r2 = 0.02, p = 0.06; Fig. 2A). To determine 
the effect of different levels of drinking and %BF, we next performed separate analyses by 
dividing the patients into quartiles based on the levels of alcohol consumption. We found 
that there was no association between alcohol consumption and %BF for participants in the 
1st and 2nd quartiles (Fig. 2B and C). However, the %BF was significantly decreased with 
increased alcohol consumption, specifically, drinking in the 3rd (r2 = 0.11, p = 0.03; Fig. 
2D) and 4th quartiles (r2 = 0.32, p = 0.005; Fig. 2E).
Percentage of body fat was negatively correlated with serum Pref-1
To test the hypothesis that the increased levels of Pref-1 observed in excessive drinkers 
inhibited adipogenesis, and thus reduced the %BF, we next determined the association 
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between %BF and the levels of serum Pref-1. We observed an inverse correlation between 
the serum Pref-1 and the %BF (r2 = 0.02, p = 0.04; Fig. 3A). We also performed an 
additional analysis to further determine the relationship of serum Pref-1 and percentage of 
body fat, when stratified by different quartiles of alcohol consumption. We found that higher 
levels of Pref-1 were correlated with lower %BF at all levels of alcohol consumption (Fig. 
3B–E).
The levels of serum free fatty acids were increased in excessive drinkers and correlated 
with serum Pref-1 levels
Since excessive alcohol drinking led to a decrease in %BF, we hypothesized that this would 
reduce the ability of adipose tissues to store TG, as reflected by increasing serum FFA. We 
found that the levels of serum free fatty acids were significantly higher in excessive drinkers 
(2.3 vs. 0.42 mmol/L, p < 0.001; Table 1 and Fig. 4A). Since serum albumin levels may 
affect the levels of free fatty acid, we also did an analysis of FFA corrected with serum 
albumin (Table 1). We again found that the FFA:albumin ratio was significantly higher in 
excessive drinkers (0.62 ± 0.23 vs. 0.1 ± 0.07, p = 0.0001). Their levels are positively 
associated with total alcohol consumption during the previous 30 days (r2 = 0.66, p < 
0.0001; Fig. 4B). Interestingly, when we analyzed the relationship between serum Pref-1 
and serum FFA to test the hypothesis that decreasing %BF by Pref-1 is associated with an 
increase in serum FFA, we found that serum Pref-1 is strongly associated with serum free 
fatty acids (r2 = 0.33, p < 0.0001; Fig. 4C).
No gender differences found in the serum Pref-1 and the levels of alcohol consumption
Women generally have a higher %BF than men. To determine the influence of gender and 
alcohol consumption on the levels of serum Pref-1, we analyzed our data stratified by 
gender. The serum Pref-1 was significantly higher in males with excessive drinking (n = 44) 
compared to control males (n = 66, 0.13 ± 0.32 vs. 0.03 ± 0.06 ng/mL, p < 0.001). Likewise, 
females with excessive drinking (n = 29) had higher levels of serum Pref-1 when compared 
to female controls (n = 6, 0.33 ± 0.13 vs. 0.08 ± 0.03, p < 0.001). We also analyzed the 
levels of Pref-1 in those with heavy alcohol consumption (n = 97). We found no gender 
differences in the levels of Pref-1 in this group (male and female: 0.32 ± 0.13 and 0.32 ± 
0.14, respectively, p = 0.87).
Discussion
This is the first study to demonstrate an association between Pref-1 and %BF as well as the 
levels of alcohol consumptions in human subjects. We show here that i) excessive alcohol 
use is associated with increased levels of serum Pref-1 regardless of gender, ii) Pref-1 is 
negatively associated with %BF, and iii) Pref-1 concentration is positively correlated with 
the levels of serum FFA.
Pref-1, a trans-membrane protein highly expressed in the pre-adipocytes, is a member of the 
EGF-like family of proteins. It is an important negative regulator of adipocyte differentiation 
(Sul, 2009). In murine models, over-expression of Pref-1 results in mice with significantly 
reduced fat mass (Sul, 2009). It has been observed that subjects with chronic and heavy 
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alcohol use had significantly lower %BF when compared to controls (Addolorato et al., 
1997), although the exact mechanism has not yet been explained. In this study, we 
demonstrated that serum Pref-1 was higher in excessive drinkers and its levels were 
significantly associated with the amount of alcohol consumption. Further, we showed that 
the higher levels of Pref-1 were in fact negatively correlated with the %BF. Our results 
suggest that Pref-1 could be a mechanistic link between alcohol use and the adipose tissue 
biology.
Heavy alcohol drinking impairs lipolysis and increases free fatty acid fluxes from adipose 
tissue to the liver, which eventually can contribute to hepatic steatosis (Zhong et al., 2012). 
This liver-adipose tissue axis is being recognized as an important pathway to maintain body 
lipid homeostasis. Our study showed that serum FFA was strongly correlated with the 
amount of alcohol consumption, suggesting an increase in lipolysis in those with excessive 
alcohol use. Of importance, we suggest that this might be related to high serum Pref-1 and a 
decrease in %BF. In general, adipose tissue mass is determined by the storage and removal 
of triglycerides in the adipocytes. It is known that the rate of triglyceride removal from 
adipose tissue is increased due to lipolysis in chronic alcohol drinkers (Zhong et al., 2012). 
However, our data suggest that alcohol might also interfere with the differentiation of pre-
adipocytes into adipocytes by increasing levels of Pref-1. Estimates of adipocyte turnover 
rate and adipocyte death in humans vary greatly, from a low of 10% per year determined by 
analyzing the integration of 14C derived from nuclear bomb tests into genomic DNA 
(Spalding et al., 2008) to a high of greater than 60% per year (0.16–0.29% per day) by 2H2O 
long-term labeling with 2H2O (Strawford, Antelo, Christiansen, & Hellerstein, 2004). The 
turnover rates are believed to be substantially higher for pre-adipocytes than adipocytes, 
4.5% and 0.16– 0.29% per day, respectively (Strawford et al., 2004). It is plausible that 
alcohol reduced the %BF by reducing the replacement of adipocytes secondary to high 
Pref-1.
This study has a few limitations. One would argue that the effects of alcohol on adipose 
tissue and alcoholic steatosis depend not only on the amount of alcohol consumption but 
also the duration of use. Alcohol consumption during the previous month does not provide a 
measure of life-time alcohol use. In our study, all excessive drinkers have an alcohol use 
disorder and the duration of heavy alcohol use ranged from 5–15 years. It is difficult to 
estimate the amount of lifetime alcohol consumption; however, a previous report has shown 
correlations between daily reports of drinking pattern/amount and TLFB (Searles, Helzer, & 
Walter, 2000). Further, TLFB is established as an effective measure of the amount of 
alcohol consumption (Collins et al., 2008; Sobell et al., 1988). Thus, we believed that it is 
justified to use the amount of alcohol consumption over the previous month as the 
independent variable in our study. We also do not know what duration of drinking is 
required to affect Pref-1 levels. Next, the %BF in our study was calculated based on the 
anthropometric measurement, not from a body composition analyzer (such as BOD POD). 
However, the formula that we used to estimate the %BF showed a high correlation with 
direct body fat measurement in other studies (Kagawa et al., 2008).
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In summary, we have shown that Pref-1 is increased in heavy drinkers, and propose that this 
may reflect an important role of alcohol in adipose tissue biology. Further studies are needed 
to delineate the role of Pref-1 and its clinical significance in subjects with heavy alcohol use.
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(A) Dot plot demonstrating the levels of serum Pref-1 in excessive drinkers and non-
excessive drinkers (B) The linear regression analysis between serum Pref-1 and alcohol 
consumption in the previous 30 days (C–F) The linear regression analysis between serum 
Pref-1 and the levels of alcohol consumption stratified by quartiles (C for Q1, D for Q2, E 
for Q3, and F for Q4)
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The relationship between %BF and the levels of alcohol consumption in the previous 30 
days (A) The linear regression analysis between %BF and the levels of alcohol consumption 
in the previous 30 days (B–E) The linear regression analysis between %BF and the levels of 
alcohol consumption stratified by quartiles (B for Q1, C for Q2, D for Q3, and E for Q4)
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(A) The relationship between serum Pref-1 and %BF in all participants (B–E) The linear 
regression analysis between serum Pref-1 and the levels of %BF of subjects with different 
degrees of alcohol consumption stratified by quartiles (B for Q1, C for Q2, D for Q3, and E 
for Q4)
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(A) Dot plot demonstrating the levels of serum free fatty acids (FFA) in excessive drinkers 
and non-excessive drinkers (B) The relationship between serum FFA and the levels of 
alcohol consumption in the previous 30 days (C) The linear regression analysis between 
serum Pref-1 and FFA %BF and the levels of alcohol consumption in the previous 30 days
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Table 1
Selected demographic, clinical and laboratory characteristics of participants with non-excessive and excessive 
drinking
Non-excessive drinkers (n = 51) Excessive drinkers (n = 97) p value
Age (years) 31.8 ± 9.3 40.9 ± 12.2 < 0.01
Males (n, %) 45 (88) 67 (70) 0.01
Race (Caucasian, n, %) 43 (84) 78 (80) 0.12
Smoking (n, %) 29 (56%) 74 (76%) 0.01
Height (cm) 176.7 ± 7.1 175.1 ± 8.9 0.27
Weight (kg) 89.9 ± 15 85.5 ± 19.5 0.16
BMI (kg/m2) 28.7 ± 4.2 27.9 ± 6.2 0.38
Waist circumference (cm) 98.1 ± 11.6 95.8 ± 12.9 0.30
AUDIT-C scores 4.2 ± 4.0 26.7 ± 7.3 < 0.001
Total standard drinks previous 30 days 15.2 ± 15.2 241.2 ± 146.8 < 0.001
Average drinks per drinking day 2.4 ± 2.2 12.2 ± 6.4 < 0.001
Creatinine (mg/dL) 1.0 ± 0.2 0.9 ± 0.2 0.11
Albumin (g/dL) 4.2 ± 0.44 3.8 ± 0.4 0.001
MCV (Fl) 90.0 ± 3.9 92.6 ± 6.5 0.01
AST (U/L) 23.2 ± 10.2 29.8 ± 17.9 0.02
ALT (U/L) 29.7 ± 19.6 44.7 ± 17.7 < 0.001
GGT (U/L) 35.2 ± 27.6 89.8 ± 9.2 < 0.001
%Carbohydrate deficient transferrin 1.4 ± 0.8 2.6 ± 1.3 < 0.01
Percentage of body fat 31.7 ± 5.7 29.7 ± 4.7 0.03
Serum Pref-1 (ng/mL) 0.13 ± 0.06 0.32 ± 0.13 < 0.01
Free fatty acid (mmol/L) 0.42 ± 0.28 2.31 ± 0.78 < 0.001
Free fatty acid/serum albumin ratio 0.1 ± 0.07 0.62 ± 0.23 0.0001
The levels of alcohol consumption were dichotomized into non-excessive and excessive drinking using the NIAAA definition.
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